NM_001105206.3:c.503G>A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 4P and 4B. PP3_StrongBS2
The NM_001105206.3(LAMA4):c.503G>A(p.Arg168Lys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000391 in 1,612,520 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. R168R) has been classified as Likely benign.
Frequency
Consequence
NM_001105206.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathy 1JJInheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LAMA4 | NM_001105206.3 | c.503G>A | p.Arg168Lys | missense_variant, splice_region_variant | Exon 5 of 39 | ENST00000230538.12 | NP_001098676.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LAMA4 | ENST00000230538.12 | c.503G>A | p.Arg168Lys | missense_variant, splice_region_variant | Exon 5 of 39 | 1 | NM_001105206.3 | ENSP00000230538.7 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152216Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000558 AC: 14AN: 251054 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1460304Hom.: 0 Cov.: 30 AF XY: 0.0000220 AC XY: 16AN XY: 726572 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000184 AC: 28AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74354 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 1JJ Uncertain:2
This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 168 of the LAMA4 protein (p.Arg168Lys). This variant is present in population databases (rs200368819, gnomAD 0.07%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 32746448). ClinVar contains an entry for this variant (Variation ID: 213597). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not provided Uncertain:1
Identified in a pediatric patient with DCM in published literature (Burstein et al., 2021); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 32746448) -
Cardiovascular phenotype Uncertain:1
The p.R168K variant (also known as c.503G>A), located in coding exon 4 of the LAMA4 gene, results from a G to A substitution at nucleotide position 503. The arginine at codon 168 is replaced by lysine, an amino acid with highly similar properties. This change occurs in the last base pair of coding exon 4, which makes it likely to have some effect on normal mRNA splicing; however, loss of function of LAMA4 has not been clearly established as a mechanism of disease. These nucleotide and amino acid positions are highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. In addition, as a missense substitution the in silico prediction for this alteration is inconclusive. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at